CL
stock NYSEKey stats
- Open
- $90.05
- -0.33%
- Close
- $90.44
- +0.10%
- Current
- $90.44
- Prev close
- $90.35
- Today
- 4.65M
- 3-mo avg
- 5.94M
Fundamentals
Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.
At 34x, investors are paying up; a fair amount of future growth is already in the price.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 2.3% yield is a healthy, generally sustainable level of cash income.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 10.5% margin is solid, in the ordinary range for a profitable company.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
A 3948.1% return on equity is strong; the company compounds owners' capital well.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 13.1% return on assets is strong; the company squeezes good profit from its assets.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
At 295.65, the company leans heavily on borrowing, which adds risk if results weaken.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 0.83, short-term assets fall short of short-term bills; liquidity is tight.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 1.4% from the prior year: steady, modest expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income fell 26.2% from the prior year; profit is shrinking.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financials
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | $17.4B | $18.0B | $19.5B | $20.1B | $20.4B |
| Net income | $2.2B | $1.8B | $2.3B | $2.9B | $2.1B |
| Diluted EPS | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 |
| Dividend / share | $1.79 | $1.86 | $1.91 | $2.48 | $2.08 |
| Total assets | $15.0B | $15.7B | $16.4B | $16.0B | $16.3B |
| Total liabilities | $14.1B | $14.9B | $15.4B | $15.5B | $16.0B |
| Shareholder equity | $609.0M | $401.0M | $609.0M | $212.0M | $54.0M |
| Q3-2023 | Q1-2024 | Q2-2024 | Q3-2024 | Q1-2025 | Q2-2025 | Q3-2025 | Q1-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $5.1B | $5.1B | $5.0B | $4.9B | $5.1B | $5.1B | $5.3B |
| Net income | $708.0M | $683.0M | $731.0M | $737.0M | $690.0M | $743.0M | $735.0M | $646.0M |
| Diluted EPS | $0.86 | $0.83 | $0.89 | $0.90 | $0.85 | $0.91 | $0.91 | $0.80 |
| Dividend / share | $0.48 | $0.98 | $0.50 | $0.50 | $0.52 | $0.52 | $0.52 | $0.53 |
Recent SEC filings
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report